JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Sensitivity Analysis of a New Cancer Risk Assessment Tool That Evaluates Salivary Polyamines

  • 0Division of Research and Treatment for Oral and Maxillofacial Congenital Anomalies, School of Dentistry, Aichi Gakuin University, Nagoya, JPN.
Cureus +

|

September 17, 2025

|

September 17, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

The SalivaChecker® test showed a 68.2% sensitivity in detecting cancer risk in patients with confirmed cancer. Further research is needed to determine its specificity in healthy individuals.

Area Of Science

  • Oncology
  • Biomarker Discovery
  • Diagnostic Testing

Background

  • A novel salivary-polyamine analysis method, SalivaChecker®, has been developed for cancer risk assessment.
  • Limited studies exist on the utility of SalivaChecker® in patients already diagnosed with cancer.

Purpose Of The Study

  • To evaluate the sensitivity of the SalivaChecker® test in individuals with confirmed cancer diagnoses.

Main Methods

  • The SalivaChecker® test was administered to 66 patients diagnosed with cancer.
  • The test assessed the risk for six cancer types: lung, pancreatic, gastric, colorectal, breast, and oral cancers.

Main Results

  • The overall cancer detection rate was 68.2% across all participants.
  • Specific detection rates varied by cancer type, with lung cancer at 92.9% (13/14) and colorectal cancer at 70.6% (12/17) for risk detection.
  • The accuracy in identifying the specific cancer site (overall cancer site detection rate) was 28.8%.

Conclusions

  • The SalivaChecker® test demonstrated a sensitivity of 68.2% in detecting cancer risk in patients with confirmed cancer.
  • Future investigations should focus on assessing the test's specificity in individuals without cancer to fully understand its clinical utility.

Keywords: